title: Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter.
authors.affiliation: Department of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands.
authors.forename: J E
authors.initials: JE
authors.lastname: Lindeboom
authors.forename: J H
authors.initials: JH
authors.lastname: Kingma
authors.forename: H J
authors.initials: HJ
authors.lastname: Crijns
authors.forename: P H
authors.initials: PH
authors.lastname: Dunselman
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001282:Atrial Flutter / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010627:Phenethylamines / Q000008:administration & dosage / Q000627:therapeutic use*; D026902:Potassium Channel Blockers; D012449:Safety; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000889:Anti-Arrhythmia Agents; D010627:Phenethylamines; D026902:Potassium Channel Blockers; D013449:Sulfonamides; C063533:dofetilide